{"entity":{"id":"philippe-bergerot","kind":"person","name":"Philippe Bergerot","aka":[],"tldr":"Radiation oncologist who has presided over the Ligue nationale contre le cancer, France's national cancer charity, since 2024.","summary":"Philippe Bergerot is President of the Ligue nationale contre le cancer, the French national cancer charity that funds research, supports patients and campaigns on prevention. He is a cancer physician and radiotherapist and was elected to lead the organisation's board in June 2024. He chairs a seven member bureau that prepares and oversees the decisions of the board of directors.","asOf":"2026-09-10","links":[{"label":"Source: Ligue nationale contre le cancer, Qui sommes-nous (bureau)","url":"https://www.ligue-cancer.net/qui-sommesnous"}],"tags":["leadership","clinician-scientist","radiation-oncology","charity"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["ligue-contre-le-cancer"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["bulletin-du-cancer"],"dependsOn":[],"notes":[],"role":"President of the Ligue nationale contre le cancer (since 2024)","institutionId":"ligue-contre-le-cancer","specialisms":["Radiation oncology","Cancer charity governance","Patient advocacy"],"profiles":[{"label":"Ligue governance page","url":"https://www.ligue-cancer.net/qui-sommesnous"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Bergerot+P%5BAuthor%5D"}],"papers":[{"title":"Patients acteurs et formation en oncologie pour futurs médecins et pharmaciens","journal":"Bulletin du Cancer","year":2021,"doi":"10.1016/j.bulcan.2020.10.023"},{"title":"Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma","journal":"JNCI: Journal of the National Cancer Institute","year":1999,"doi":"10.1093/jnci/91.24.2081"},{"title":"Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems","journal":"International Journal of Radiation Oncology*Biology*Physics","year":2003,"doi":"10.1016/s0360-3016(02)03819-1"}]},"route":"/people/philippe-bergerot/","neighbours":{"institution":[{"id":"ligue-contre-le-cancer","kind":"institution","name":"Ligue nationale contre le cancer","route":"/institutions/ligue-contre-le-cancer/"}],"journal":[{"id":"bulletin-du-cancer","kind":"journal","name":"Bulletin du cancer","route":"/journals/bulletin-du-cancer/"}]}}